Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Acute Effects of Oculomotor Exercises on Posturography and Gait Analysis Parameters in Regular Exercisers (OMEX-PG)

16 de julho de 2026 atualizado por: Vedat Kavak, Ege University

The Acute Effects of Oculomotor Exercises on Static Posturography and Gait Analysis Parameters in Regular Exercisers

This study aims to investigate the acute effects of a single-session oculomotor exercise program on static posturography and gait analysis parameters in healthy individuals who exercise regularly. Postural control and gait are complex sensorimotor functions that depend on the integration of visual, vestibular, somatosensory, and motor systems. Eye movements and gaze stabilization may contribute to postural orientation and locomotor control by influencing visual-vestibular integration, head-eye coordination, and sensorimotor adaptation. However, the immediate effects of short-duration oculomotor exercise programs on postural sway and gait-related parameters in regular exercisers have not been fully clarified.

This study is designed as a single-group, within-session, pre-post interventional study. Participants will undergo baseline assessments, complete a single session of oculomotor exercises, and then be reassessed after the intervention in the same testing session. The study population will consist of healthy adults who exercise regularly and meet the predefined eligibility criteria. Individuals with musculoskeletal injury, neurological or vestibular disorders, visual conditions that may affect balance or eye movement performance, or any condition limiting participation in the testing procedures will be excluded.

Static posturography will be performed using the HUR SmartBalance BTG4 system to evaluate postural sway under different sensory conditions. Measurements will be obtained during quiet standing with eyes open on a firm surface, eyes closed on a firm surface, eyes open on a foam surface, and eyes closed on a foam surface. The main posturography variables will include sway area, trace length, sway velocity, lateral sway, and anterior-posterior sway.

Gait analysis will be performed before and after the intervention using the DIERS Pedogait system. Spatiotemporal, phase-related, and center-of-pressure-based gait parameters will be recorded. These parameters may include step length, stride length, step time, stride time, track width, cadence, stance phase, swing phase, double support, pre-swing, and center-of-pressure-related gait variables.

The oculomotor exercise program will include three main components: extraocular eye movement exercises, vestibulo-ocular and cervico-ocular gaze stabilization exercises, and accommodation exercises. During extraocular eye movement exercises, participants will be asked to follow a visual target with eye movements while keeping the head stable. During gaze stabilization exercises, participants will maintain visual fixation on a target while performing controlled head movements and walking steps. During accommodation exercises, participants will alternate focus between a near target and a distant target. The exercises will be performed at different speeds to stimulate oculomotor control, gaze stabilization, and visual focusing mechanisms.

The primary outcome of the study is the change in sway area from baseline to the post-intervention assessment. Secondary outcomes include changes in other static posturography parameters and gait analysis variables. By evaluating both postural sway and gait-related outcomes, this study aims to provide preliminary evidence on whether a short oculomotor exercise session may produce immediate changes in postural control and walking characteristics in regular exercisers.

Visão geral do estudo

Tipo de estudo

Intervencional

Inscrição (Estimado)

51

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Bornova
      • Izmir, Bornova, Turquia (Türkiye), 35100
        • Ege University Faculty of Medicine, Department of Sports Medicine

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto

Aceita Voluntários Saudáveis

Sim

Descrição

Inclusion Criteria:

  • Healthy adults aged 18 to 50 years
  • Regular participation in exercise
  • Ability to walk independently without an assistive device
  • Ability to understand and follow the study procedures
  • Ability to complete the oculomotor exercise program, static posturography assessment, and gait analysis
  • Provision of written informed consent

Exclusion Criteria:

  • Acute musculoskeletal injury or pain that could affect balance, gait, or exercise performance
  • Neurological disease that could affect balance, gait, or oculomotor control
  • Vestibular disorder or current symptoms of dizziness or vertigo
  • Visual or ocular disorder that could affect visual fixation, eye movements, or balance assessment
  • Use of medication that could affect balance, coordination, alertness, or gait
  • Inability to walk independently
  • Inability to complete the oculomotor exercise intervention or assessment procedures
  • Any medical condition considered by the investigator to interfere with safe participation or the validity of the assessments

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Outro
  • Alocação: N / D
  • Modelo Intervencional: Atribuição de grupo único
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Oculomotor Exercise Group
Participants in this single-arm group will receive a single-session oculomotor exercise program. Static posturography and gait analysis assessments will be performed before and after the intervention within the same testing session.
The intervention consists of a single-session oculomotor exercise program including extraocular eye movement exercises, vestibulo-ocular and cervico-ocular gaze stabilization exercises, and accommodation exercises. During extraocular eye movement exercises, participants will follow a visual target with eye movements while keeping the head stable. During gaze stabilization exercises, participants will maintain visual fixation on a target while performing controlled head movements and walking steps. During accommodation exercises, participants will alternate visual focus between a near target and a distant target. Exercises will be performed at different speeds within the same session.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Change From Baseline in Sway Area Under Four Sensory Conditions
Prazo: Baseline and 15 minutes after the intervention
Sway area was assessed during 30 seconds of quiet standing using the HUR SmartBalance BTG4 static posturography system. Measurements were obtained under four sensory conditions: eyes open on a firm surface, eyes closed on a firm surface, eyes open on a foam surface, and eyes closed on a foam surface. Condition-specific sway area values were expressed using the same unit of measure (mm²). The change from baseline to 15 minutes after the single-session oculomotor exercise intervention was evaluated separately for each sensory condition..
Baseline and 15 minutes after the intervention

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Change From Baseline in Trace Length Under Four Sensory Conditions
Prazo: Baseline and 15 minutes after the intervention
Trace length was assessed during 30 seconds of quiet standing using the HUR SmartBalance BTG4 static posturography system. Measurements were obtained under eyes-open firm-surface, eyes-closed firm-surface, eyes-open foam-surface, and eyes-closed foam-surface conditions. Condition-specific trace length values were expressed using the same unit of measure (mm). The change from baseline to 15 minutes after the intervention was evaluated separately for each sensory condition.
Baseline and 15 minutes after the intervention
Change From Baseline in Single-Support Phase Percentage
Prazo: Baseline and 15 minutes after the intervention
Right and left single-support phase values were assessed during barefoot treadmill walking at 3 km/h using the DIERS Pedogait system. Single support was expressed as a percentage of the gait cycle. The change from baseline to 15 minutes after the intervention was evaluated separately for each side.
Baseline and 15 minutes after the intervention
Change From Baseline in Sway Velocity Under Four Sensory Conditions
Prazo: Baseline and 15 minutes after the intervention
Sway velocity was assessed during 30 seconds of quiet standing using the HUR SmartBalance BTG4 static posturography system. Measurements were obtained under eyes-open firm-surface, eyes-closed firm-surface, eyes-open foam-surface, and eyes-closed foam-surface conditions. Condition-specific sway velocity values were expressed using the same unit of measure (mm/s) . The change from baseline to 15 minutes after the intervention was evaluated separately for each sensory condition.
Baseline and 15 minutes after the intervention
Change From Baseline in Mediolateral Sway Under Four Sensory Conditions
Prazo: Baseline and 15 minutes after the intervention
Mediolateral sway was assessed during 30 seconds of quiet standing using the HUR SmartBalance BTG4 static posturography system. Measurements were obtained under eyes-open firm-surface, eyes-closed firm-surface, eyes-open foam-surface, and eyes-closed foam-surface conditions. Condition-specific mediolateral sway values were expressed using the same unit of measure (mm). The change from baseline to 15 minutes after the intervention was evaluated separately for each sensory condition.
Baseline and 15 minutes after the intervention
Change From Baseline in Anteroposterior Sway Under Four Sensory Conditions
Prazo: Baseline and 15 minutes after the intervention
Anteroposterior sway was assessed during 30 seconds of quiet standing using the HUR SmartBalance BTG4 static posturography system. Measurements were obtained under eyes-open firm-surface, eyes-closed firm-surface, eyes-open foam-surface, and eyes-closed foam-surface conditions. Condition-specific anteroposterior sway values were expressed using the same unit of measure (mm). The change from baseline to 15 minutes after the intervention was evaluated separately for each sensory condition.
Baseline and 15 minutes after the intervention
Change From Baseline in Romberg Quotient on Firm and Foam Surfaces
Prazo: Baseline and 15 minutes after the intervention
The Romberg quotient was calculated using static posturography measurements obtained during eyes-open and eyes-closed standing. Separate Romberg quotient values were calculated for the firm and foam surfaces using the HUR SmartBalance BTG4 system. Both values were expressed using the same unit of measure. The change from baseline to 15 minutes after the intervention was evaluated separately for each surface.
Baseline and 15 minutes after the intervention
Change From Baseline in Step Length
Prazo: Time Frame: Baseline and 15 minutes after the intervention
Right and left step length values were assessed during barefoot treadmill walking at 3 km/h using the DIERS Pedogait system. Right and left values represented the same outcome variable and were expressed using the same unit of measure. The change from baseline to 15 minutes after the intervention was evaluated separately for each side.
Time Frame: Baseline and 15 minutes after the intervention
Change From Baseline in Track Width
Prazo: Baseline and 15 minutes after the intervention
Track width was assessed during barefoot treadmill walking at 3 km/h using the DIERS Pedogait system. Track width represents the mediolateral distance between consecutive foot placements. The change from baseline to 15 minutes after the intervention was evaluated.
Baseline and 15 minutes after the intervention
Change From Baseline in Stride Length
Prazo: Baseline and 15 minutes after the intervention
Right and left stride length values were assessed during barefoot treadmill walking at 3 km/h using the DIERS Pedogait system. Right and left values represented the same outcome variable and were expressed using the same unit of measure. The change from baseline to 15 minutes after the intervention was evaluated separately for each side.
Baseline and 15 minutes after the intervention
Change From Baseline in Step Time
Prazo: Baseline and 15 minutes after the intervention
Right and left step time values were assessed during barefoot treadmill walking at 3 km/h using the DIERS Pedogait system. Right and left values represented the same outcome variable and were expressed using the same unit of measure. The change from baseline to 15 minutes after the intervention was evaluated separately for each side.
Baseline and 15 minutes after the intervention
Change From Baseline in Stride Time
Prazo: Baseline and 15 minutes after the intervention
Right and left stride time values were assessed during barefoot treadmill walking at 3 km/h using the DIERS Pedogait system. Right and left values represented the same outcome variable and were expressed using the same unit of measure. The change from baseline to 15 minutes after the intervention was evaluated separately for each side.
Baseline and 15 minutes after the intervention
Change From Baseline in Stance Phase Percentage
Prazo: Baseline and 15 minutes after the intervention
Right and left stance phase values were assessed during barefoot treadmill walking at 3 km/h using the DIERS Pedogait system. Stance phase was expressed as a percentage of the gait cycle. The change from baseline to 15 minutes after the intervention was evaluated separately for each side.
Baseline and 15 minutes after the intervention
Change From Baseline in Pre-Swing Phase Percentage
Prazo: Baseline and 15 minutes after the intervention
Right and left pre-swing phase percentages were assessed during barefoot treadmill walking at 3 km/h using the DIERS Pedogait system. Pre-swing was expressed as a percentage of the gait cycle. The change from baseline to 15 minutes after the intervention was evaluated separately for each side.
Baseline and 15 minutes after the intervention
Change From Baseline in Double-Support Phase Percentage
Prazo: Baseline and 15 minutes after the intervention
Right and left double-support phase percentages were assessed during barefoot treadmill walking at 3 km/h using the DIERS Pedogait system. Double support was expressed as a percentage of the gait cycle. The change from baseline to 15 minutes after the intervention was evaluated separately for each side.
Baseline and 15 minutes after the intervention
Change From Baseline in Swing Phase Percentage
Prazo: Baseline and 15 minutes after the intervention
Right and left swing phase values were assessed during barefoot treadmill walking at 3 km/h using the DIERS Pedogait system. Swing phase was expressed as a percentage of the gait cycle. The change from baseline to 15 minutes after the intervention was evaluated separately for each side.
Baseline and 15 minutes after the intervention
Change From Baseline in Load Response Phase Percentage
Prazo: Baseline and 15 minutes after the intervention
Right and left load response phase values were assessed during barefoot treadmill walking at 3 km/h using the DIERS Pedogait system. Load response was expressed as a percentage of the gait cycle. The change from baseline to 15 minutes after the intervention was evaluated separately for each side.
Baseline and 15 minutes after the intervention
Change From Baseline in Single-Support Phase Percentage
Prazo: Baseline and 15 minutes after the intervention
Right and left single-support phase percentages were assessed during barefoot treadmill walking at 3 km/h using the DIERS Pedogait system. Single support was expressed as a percentage of the gait cycle. The change from baseline to 15 minutes after the intervention was evaluated separately for each side.
Baseline and 15 minutes after the intervention

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

2 de setembro de 2025

Conclusão Primária (Estimado)

5 de setembro de 2026

Conclusão do estudo (Estimado)

11 de novembro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

12 de julho de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

16 de julho de 2026

Primeira postagem (Real)

21 de julho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

21 de julho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

16 de julho de 2026

Última verificação

1 de julho de 2026

Mais Informações

Termos relacionados a este estudo

Termos MeSH relevantes adicionais

Outros números de identificação do estudo

  • EUTF-OKULO-33058

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

Individual participant data will not be shared due to institutional and ethical restrictions and because the informed consent process did not include permission for public sharing of individual-level data.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Ensaios clínicos em Oculomotor Exercise Program

Se inscrever